****
69th Legislature 2025 SB 475.1
- 1 - Authorized Print Version – SB 475
1 SENATE BILL NO. 475
2 INTRODUCED BY D. EMRICH
3
4 A BILL FOR AN ACT ENTITLED: “AN ACT PROHIBITING ALUMINUM IN VACCINES; PROVIDING
5 ENFORCEMENT; PROVIDING FOR NOTIFICATION AND IMPLEMENTATION; AND PROVIDING
6 EFFECTIVE DATES.”
7
8 WHEREAS, aluminum is used to induce allergies in animals by pairing aluminum with a silicone-
9 covered food molecule to induce a permanent food allergy for study, and this is used to study treatments for
10 food allergies; and
11 WHEREAS, when a child receives a vaccine that contains aluminum, the aluminum can create an
12 allergy to anything that the child comes into contact with in the ambient environment; and
13 WHEREAS, a child receiving a vaccine that contains aluminum is 30 times more likely to develop an
14 allergic rhinitis than a child that has received no vaccines, due to the aluminum forcing the body into a hyper-
15 reactive state; and
16 WHEREAS, it is possible for vaccines to be manufactured without aluminum as an ingredient.
17
18 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MONTANA:
19
20 NEW SECTION. Section 1. (1) A vaccine
21 containing aluminum as an ingredient may not be used or sold within the state. A health care provider, as
22 defined in 50-4-106, may not administer a vaccine that contains aluminum as an ingredient.
23 (2) The department of public health and human services may use its authority pursuant to 50-1-
24 202 to enforce this section.
25 (3) The department of labor and industry may maintain a licensing action against a health care
26 provider for a violation of this section.
27
28 NEW SECTION. Section 2. (1) Within 30 days of [the ****
69th Legislature 2025 SB 475.1
- 2 - Authorized Print Version – SB 475
1 effective date of this section], the department of public health and human services shall provide notice of
2 [sections 1 and 2] to each vaccine manufacturer, vaccine distributor, and health care provider in the state.
3 (2) Within 1 year of [the effective date of this section], a vaccine manufacturer or vaccine
4 distributor shall submit an implementation plan to the department of public health and human services. The
5 implementation plan must include:
6 (a) a reasonable timeline for compliance not to exceed 90 days;
7 (b) provisions for the removal of vaccines containing aluminum from all retail, pharmacy, and
8 health care establishments in the state; and
9 (c) provisions for the distribution of aluminum-free vaccines to pharmacy and health care providers
10 in the state;
11 (3) Within 15 days of the date that aluminum-free vaccines become available for human use, the
12 department of public health and human services shall certify to the code commissioner that aluminum-free
13 vaccines are available.
14 (4) Within 30 days of the department of public health and human services certifying the availability
15 of aluminum-free vaccines, a vaccine manufacturer or vaccine distributor shall proceed with the implementation
16 plan submitted pursuant to subsection (2).
17
18 NEW SECTION. Section 3. [Sections 1 and 2] are intended to be codified
19 as a new part in Title 50, chapter 17, and the provisions of Title 50, chapter 17, apply to [sections 1 and 2].
20
21 NEW SECTION. Section 4. (1) Except as provided in
22 subsection (2), [this act] is effective on passage and approval.
23 (2) [Section 1] is effective on the date that the director of the department of public health and
24 human services certifies to the code commissioner that aluminum-free vaccines are available. The director of
25 the department of public health and human services shall submit certification within 15 days of the occurrence
26 of the contingency.
27 - END -